Skip to main navigation Skip to search Skip to main content

Basic Fibroblast Growth Factor Expression after Gingival Mesenchymal Stem Cell’s Metabolite Provision in Lipopolysaccharide induce inflammatory bone resorption in vivo

  • Dwi Rahmawati
  • , Alexander Patera Nugraha*
  • , Alivianda Zahrina Saraya
  • , Nastiti Faradilla Ramadhani
  • , Wibi Riawan
  • , Igo Syaiful Ihsan
  • , Diah Savitri Ernawati
  • , Ida Bagus Narmada
  • , Tania Saskianti
  • , Fianza Rezkita
  • , Andari Sarasati
  • , Albertus Putera Nugraha
  • , Tengku Natasha Eleena Binti
  • , Tengku Ahmad Noor
  • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

balanced. Some chronic disease, such us periodontitis could affect the bone remodelling causing bone resorption is higher than bone formation. Basic Fibroblast Growth Factors (bFGF) has role on osteogenesis which can help in increasing bone formation. Gingival Mesenchymal Stem Cells’s Metabolite (GM SCM) is medical wasted products from Mesenchymal Stem Cells (MSC) which has various function. Aim of this study is to investigate the metabolites of GM SC effect on bFGF expression in inflammatory bone resorption caused by lipopolysaccharide. The 20 experimental animals were separated into four groups: control (C): 100 g PBS day 1-7, LPS group: 100 g LPS day 1-7, LPS+GM SCs' metabolite group: 100 g LPS + 100 g GM SCs' metabolite day 1-1-7, and GM SCs' metabolite group: 100 g M-GM SCs day 1-7. Escherichia Coli LPS was employed to trigger bone resorption on the calvaria of an animal model. The dose of GM SCs metabolite administered is 100 g once day through subcutaneous injection. Furthermore, on day 8, all samples were sacrificed by cervical dislocation. To count the number of bFGF positive expressions in osteoblast in the calvaria of animal models, bFGF monoclonal antibody and Diaminobenzidine (DAB) is added, resulting in a brown precipitate developing where the antibody has attached. The statistical analysis was performed to examine the significantly different between groups (p<0.05). The expression of bFGF was significantly decreased in LPS induced bone resorption group (LPS group), however, after GM SCs’ metabolite provision, bFGF expression was significantly elevated in GMSCs metabolite and LPS induced bone resorption (LPS+GM SCs’ metabolite group) with significantly different (p=0.0001; p<0.05). The positive expression of bFGF in osteoblast was elevated after GM SCs metabolite provision in LPS-induced calvaria bone resorption in wistar rats (R. novergicus) by means of immunohistochemistry examination.

Original languageEnglish
Pages (from-to)468-471
Number of pages4
JournalJournal of International Dental and Medical Research
Volume15
Issue number2
Publication statusPublished - 2022
Externally publishedYes

Keywords

  • Dentistry
  • Gingival mesenchymal stem cells metabolite
  • Infectious disease
  • Lipopolysaccharide
  • Medicine

Fingerprint

Dive into the research topics of 'Basic Fibroblast Growth Factor Expression after Gingival Mesenchymal Stem Cell’s Metabolite Provision in Lipopolysaccharide induce inflammatory bone resorption in vivo'. Together they form a unique fingerprint.

Cite this